HOME
Donate now
EN FR
EN FR

Cancer Surveillance Branch (CSU)

Publications

All recent publications: 2024-2020

View Key Publications

 

  1. Zahed, H., Feng, X., Sheikh, M., Bray, F., Ferlay, J., Ginsburg, O., . . . Robbins, H. A. (2024). Age at diagnosis for lung, colon, breast and prostate cancers: An international comparative study. International Journal of Cancer. 154(1): 28-40. PMID: 37615573 https://doi.org/10.1002/ijc.34671           
  2. Banham, D., Roder, D., Thompson, S., Williamson, A., Bray, F., & Currow, D. (2023). The effect of general practice contact on cancer stage at diagnosis in Aboriginal and non-Aboriginal residents of New South Wales. Cancer Causes and Control. 34(10): 909-926. PMID: 37329444 https://doi.org/10.1007/s10552-023-01727-6        
  3. Bauer, M., Vetter, M., Stuckrath, K., Yohannes, M., Desalegn, Z., Yalew, T., . . . Kantelhardt, E. J. J. (2023). Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa. Cancer Immunol Res. 11(6): 720-731. PMID: 37058582 https://doi.org/10.1158/2326-6066.CIR-22-0795               
  4. Bergengren, O., Pekala, K. R., Matsoukas, K., Fainberg, J., Mungovan, S. F., Bratt, O., . . . Carlsson, S. (2023). 2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review. European Urology. 84(2): 191-206. PMID: 37202314 https://doi.org/10.1016/j.eururo.2023.04.021   
  5. Blanco-Lopez, J., Iguacel, I., Pisanu, S., Almeida, C. C. B., Steliarova-Foucher, E., Sierens, C., . . . Huybrechts, I. (2023). Role of Maternal Diet in the Risk of Childhood Acute Leukemia: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 20(7): 5428. PMID: 37048042 https://doi.org/10.3390/ijerph20075428             
  6. Budhathoki, S., Diergaarde, B., Liu, G., Olshan, A., Ness, A., Waterboer, T., . . . Hung, R. J. (2023). A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers. International Journal of Cancer. 152(10): 2069-2080. PMID: 36694401 https://doi.org/10.1002/ijc.34444
  7. Cabasag, C. J., Arnold, M., Rutherford, M., Ferlay, J., Bardot, A., Morgan, E., . . . Soerjomataram, I. (2023). Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 study. International Journal of Cancer. 152(9): 1763-1777. PMID: 36533660 https://doi.org/10.1002/ijc.34403            
  8. De Camargo Cancela, M., Monteiro Dos Santos, J. E., Lopes de Souza, L. B., Martins, L. F. L., Bezerra de Souza, D. L., Barchuk, A., . . . Pearce, A. (2023). The economic impact of cancer mortality among working-age individuals in Brazil from 2001 to 2030. Cancer Epidemiology. 86: 102438. PMID: 37579673 https://doi.org/10.1016/j.canep.2023.102438    
  9. Deshmukh, A. A., Damgacioglu, H., Georges, D., Sonawane, K., Ferlay, J., Bray, F., & Clifford, G. M. (2023). Global burden of HPV-attributable squamous cell carcinoma of the anus in 2020, according to sex and HIV status: A worldwide analysis. International Journal of Cancer. 152(3): 417-428. PMID: 36054026 https://doi.org/10.1002/ijc.34269           
  10. Ghasemi-Kebria, F., Jafari-Delouie, N., Semnani, S., Fazel, A., Etemadi, A., Norouzi, A., . . . Malekzadeh, R. (2023). Colorectal cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004-2018. Cancer Epidemiology. 86: 102415. PMID: 37442047 https://doi.org/10.1016/j.canep.2023.102415              
  11. Ghasemi-Kebria, F., Semnani, S., Fazel, A., Etemadi, A., Amiriani, T., Naeimi-Tabiei, M., . . . Malekzadeh, R. J. (2023). Esophageal and gastric cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004 to 2018. International Journal of Cancer. 153(1): 73-82. PMID: 36943026 https://doi.org/10.1002/ijc.34518           
  12. Guimarães Ribeiro, A., Ferlay, J., Piñeros, M., Dias de Oliveira Latorre, M. d. R., Tavares Guerreiro Fregnani, J. H., & Bray, F. (2023). Geographic variations in cancer incidence and mortality in the State of São Paulo, Brazil 2001–17. Cancer Epidemiology. 85: 102403. PMID: 37390700 https://doi.org/10.1016/j.canep.2023.102403
  13. Hanly, P., Ortega, M. O., Pearce, A., Cancela, M. D., Soerjomataram, I., & Sharp, L. (2023). Estimating Global Friction Periods for Economic Evaluation: A Case Study of Selected OECD Member Countries. Pharmacoeconomics. 41(9): 1093-1101. PMID: 37036642 https://doi.org/10.1007/s40273-023-01261-y    
  14. Jubber, I., Ong, S., Bukavina, L., Black, P. C., Comperat, E., Kamat, A. M., . . . Cumberbatch, M. G. (2023). Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors. European Urology. 84(2): 176-190. PMID: 37198015 https://doi.org/10.1016/j.eururo.2023.03.029   
  15. Kidayi, P. L., Pakpour, A. H., Saboonchi, F., Bray, F., Manhica, H., Mtuya, C. C., . . . Björling, G. (2023). Cross-Cultural Adaptation and Psychometric Properties of the Swahili Version of the European Organization for Research and Treatment of Cancer (EORTC) QLQ-BR45 among Breast Cancer Patients in Tanzania. Healthcare (Basel). 11(18): 15. PMID: 37761665 https://doi.org/10.3390/healthcare11182467           
  16. Kiss, Z., Kocsis, J., Nikolenyi, A., Horvath, Z., Knollmajer, K., Benedek, A., . . . Boer, K. (2023). Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011-2020. Frontiers in Oncology. 13: 1182170. PMID: 37795445 https://doi.org/10.3389/fonc.2023.1182170       
  17. Laronningen, S., Skog, A., Engholm, G., Ferlay, J., Johannesen, T. B., Kristiansen, M. F., . . . Miettinen, J. (2023). Nordcan.R: a new tool for federated analysis and quality assurance of cancer registry data. Frontiers in Oncology. 13: 1098342. PMID: 37614501 https://doi.org/10.3389/fonc.2023.1098342  
  18. Li, M., Meheus, F., Polazzi, S., Delafosse, P., Borson-Chazot, F., Seigneurin, A., . . . Thyroid Cancer Group, F. (2023). The Economic Cost of Thyroid Cancer in France and the Corresponding Share Associated With Treatment of Overdiagnosed Cases. Value in Health. 26(8): 1175-1182. PMID: 36921898 https://doi.org/10.1016/j.jval.2023.02.016          
  19. Li, M., Park, J. Y., Sheikh, M., Kayamba, V., Rumgay, H., Jenab, M., . . . Arnold, M. (2023). Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time. Gut. 72(5): 846-854. PMID: 36241389 https://doi.org/10.1136/gutjnl-2022-328233    
  20. Macciotta, A., Catalano, A., Giraudo, M. T., Weiderpass, E., Ferrari, P., Freisling, H., . . . Ricceri, F. (2023). Mediating Role of Lifestyle Behaviors in the Association between Education and Cancer: Results from the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiology, Biomarkers and Prevention. 32(1): 132-140. PMID: 36306379 https://doi.org/10.1158/1055-9965.EPI-22-0777   
  21. Mafra, A., Bardot, A., Charvat, H., Weiderpass, E., Soerjomataram, I., & Fregnani, J. (2023). Cancer survival in the northwestern of Sao Paulo State, Brazil: A population-based study. Cancer Epidemiology. 83: 102339. PMID: 36863216 https://doi.org/10.1016/j.canep.2023.102339    
  22. Mallon, B., Kaboré, R., Couitchere, L., Akonde, F. B., Narison, M. L. R., Budiongo, A., . . . Clavel, J. (2023). The feasibility of implementing Toronto childhood cancer stage guidelines and estimating the impact on outcome for childhood cancers in seven pediatric oncology units in sub-Saharan Africa. A study from the Franco-African Pediatric Oncology Group. Pediatric Blood & Cancer. 70(12): e30664. PMID: 37732944 https://doi.org/10.1002/pbc.30664    
  23. Marant Micallef, C., Charvat, H., Houot, M. T., Vignat, J., Straif, K., Paul, A., . . . Soerjomataram, I. (2023). Estimated number of cancers attributable to occupational exposures in France in 2017: an update using a new method for improved estimates. Journal of Exposure Science & Environmental Epidemiology. 33(1): 125-131. PMID: 34172838 https://doi.org/10.1038/s41370-021-00353-1              
  24. Morgan, E., Arnold, M., Gini, A., Lorenzoni, V., Cabasag, C. J., Laversanne, M., . . . Bray, F. (2023). Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 72(2): 338-344. PMID: 36604116 https://doi.org/10.1136/gutjnl-2022-327736      
  25. Myklebust, T. A., Aagnes, B., Nilssen, Y., Rutherford, M., Lambert, P. C., Andersson, T. M. L., . . . Moller, B. (2023). Improving communication of cancer survival statistics-feasibility of implementing model-based algorithms in routine publications. British Journal of Cancer. 129(5): 819-828. PMID: 37433898 https://doi.org/10.1038/s41416-023-02360-5              
  26. Ortega-Ortega, M., Hanly, P., Pearce, A., Soerjomataram, I., & Sharp, L. (2023). Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018-2040. Appl Health Econ Health Policy. 21(6): 877-889. PMID: 37552416 https://doi.org/10.1007/s40258-023-00824-6    
  27. Ribeiro, A. G., Ferlay, J., Vaccarella, S., Latorre, M., Fregnani, J., & Bray, F. (2023). Cancer inequalities in incidence and mortality in the State of Sao Paulo, Brazil 2001-17. Cancer Med. 12(15): 16615-16625. PMID: 37345901 https://doi.org/10.1002/cam4.6259       
  28. Ritter, J., Allen, S., Cohen, P. D., Fajardo, A. F., Marx, K., Loggetto, P., . . . Bhakta, N. (2023). Financial hardship in families of children or adolescents with cancer: a systematic literature review. Lancet Oncology. 24(9): E364-E375. PMID: 37657477 https://doi.org/10.1016/S1470-2045(23)00320-0             
  29. Roshandel, G., Badar, F., Barchuk, A., Roder, D. M., Sangrajrang, S., Mery, L., . . . Mosavi Jarrahi, A. (2023). REPCAN: Guideline for REporting Population-based CANcer Registry Data. Asian Pacific Journal of Cancer Prevention. 24(9): 3297-3303. PMID: 37777857 https://doi.org/10.31557/APJCP.2023.24.9.3297         
  30. Rumgay, H., Ortega-Ortega, M., Sharp, L., Lunet, N., & Soerjomataram, I. (2023). The cost of premature death from cancer attributable to alcohol: Productivity losses in Europe in 2018. Cancer Epidemiology. 84: 102365. PMID: 37058915 https://doi.org/10.1016/j.canep.2023.102365    
  31. Sawant, P., Perera, S., Jayanthi, K. G. N., Ziyad, A. I. A., Saoba, S., Ervik, M., . . . Budukh, A. (2023). Application of Rupantaran software to Sri Lankan hospitals: an innovative tool developed to merge population-based cancer registry data into CanReg5. Ecancermedicalscience. 17: 1553. PMID: 37377679 https://doi.org/10.3332/ecancer.2023.1553       
  32. Schuz, J., Ostroumova, E., Kesminiene, A., Davies, L., Ahn, H. S., Togawa, K., & Vaccarella, S. (2023). Response to Toshihide Tsuda, Yumiko Miyano and Eiji Yamamoto [1]. Environmental Health: A Global Access Science Source. 22(1): 13. PMID: 36703177 https://doi.org/10.1186/s12940-022-00952-x     
  33. Sedeta, E., Sung, H., Laversanne, M., Bray, F., & Jemal, A. (2023). Recent Mortality Patterns and Time Trends for the Major Cancers in 47 Countries Worldwide. Cancer Epidemiology, Biomarkers and Prevention. 32(7): 894-905. PMID: 37195435 https://doi.org/10.1158/1055-9965.EPI-22-1133              
  34. Singh, D., Vignat, J., Lorenzoni, V., Eslahi, M., Ginsburg, O., Lauby-Secretan, B., . . . Vaccarella, S. (2023). Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 11(2): e197-e206. PMID: 36528031 https://doi.org/10.1016/S2214-109X(22)00501-0            
  35. Soerjomataram, I., Cabasag, C., Bardot, A., Fidler-Benaoudia, M. M., Miranda-Filho, A., Ferlay, J., . . . collaborators, S. (2023). Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries. Lancet Oncology. 24(1): 22-32. PMID: 36603919 https://doi.org/10.1016/S1470-2045(22)00704-5        
  36. Song, C. V., van Gils, C. H., Yip, C. H., Soerjomataram, I., Taib, N. A. M., See, M. H., . . . Bhoo-Pathy, N. (2023). Discriminatory Ability and Clinical Utility of the AJCC7 and AJCC8 Staging Systems for Breast Cancer in a Middle-Income Setting. Diagnostics (Basel). 13(4): 674. PMID: 36832162 https://doi.org/10.3390/diagnostics13040674          
  37. Storm, H. H., Laronningen, S., & Bray, F. (2023). Do investments in cancer registry databases and tools bring added value? NORDCAN as an example. Acta Oncologica. 62(6): 535-540. PMID: 37276272 https://doi.org/10.1080/0284186X.2023.2218557               
  38. Vaccarella, S., Georges, D., Bray, F., Ginsburg, O., Charvat, H., Martikainen, P., . . . Nusselder, W. (2023). Socioeconomic inequalities in cancer mortality between and within countries in Europe: a population-based study. Lancet Reg Health Eur. 25: 100551. PMID: 36818237 https://doi.org/10.1016/j.lanepe.2022.100551               
  39. Weber, A., Mery, L., Nagy, P., Polgar, C., Bray, F., & Kenessey, I. (2023). Evaluation of data quality at the Hungarian National Cancer Registry, 2000-2019. Cancer Epidemiology. 82: 102306. PMID: 36521336 https://doi.org/10.1016/j.canep.2022.102306        
  40. Weber, A., Morgan, E., Vignat, J., Laversanne, M., Pizzato, M., Rumgay, H., . . . Bray, F. (2023). Lung cancer mortality in the wake of the changing smoking epidemic: a descriptive study of the global burden in 2020 and 2040. BMJ Open. 13(5): e065303. PMID: 37164477 https://doi.org/10.1136/bmjopen-2022-065303             
  41. Wu, L., Vaccarella, S., Feng, C. Y., Dal Maso, L., Chen, Y., Liu, W. W., . . . Li, M. (2023). Mortality among papillary thyroid cancer patients by detection route: a hospital-based retrospective cohort study. Eur Thyroid J. 12(6): e230127. PMID: 37855414 https://doi.org/10.1530/ETJ-23-0127     
  42. Xu, J., Xu, W., Choi, J., Brhane, Y., Christiani, D. C., Kothari, J., . . . Briollais, L. (2023). Large-scale whole exome sequencing studies identify two genes,CTSL and APOE, associated with lung cancer. Plos Genetics. 19(9): e1010902. PMID: 37738239 https://doi.org/10.1371/journal.pgen.1010902  
  43. Youlden, D. R., Steliarova-Foucher, E., Gini, A., Silva, N. P., & Aitken, J. F. J. (2023). The growing prevalence of childhood cancer survivors in Australia. Pediatric Blood & Cancer. 70(7): e30383. PMID: 37092826 https://doi.org/10.1002/pbc.30383       
  44. Zhang, Y., Rumgay, H., Li, M., Cao, S., & Chen, W. (2023). Nasopharyngeal Cancer Incidence and Mortality in 185 Countries in 2020 and the Projected Burden in 2040: Population-Based Global Epidemiological Profiling. JMIR Public Health Surveill. 9: e49968. PMID: 37728964 https://doi.org/10.2196/49968             
  45. Zhang, Y., Vaccarella, S., Morgan, E., Li, M., Etxeberria, J., Chokunonga, E., . . . Bray, F. (2023). Global variations in lung cancer incidence by histological subtype in 2020: a population-based study. Lancet Oncology. 24(11): 1206-1218. PMID: 37837979 https://doi.org/10.1016/S1470-2045(23)00444-8             
  46. Zheng, R., Wang, S., Zhang, S., Zeng, H., Chen, R., Sun, K., . . . Wei, W. (2023). Global, regional, and national lifetime probabilities of developing cancer in 2020. Sci Bull (Beijing). 68(21): 2620-2628. PMID: 37821267 https://doi.org/10.1016/j.scib.2023.09.041         
  47. Znaor, A., Ryzhov, A., Losada, M. L., Carvalho, A., Smelov, V., Barchuk, A., . . . Corbex, M. (2023). Breast and cervical cancer screening practices in nine countries of Eastern Europe and Central Asia: A population-based survey. J Cancer Policy. 38: 100436. PMID: 37544479 https://doi.org/10.1016/j.jcpo.2023.100436     
  48. Alkhalawi, E., Znaor, A., & Al-Zahrani, A. S. (2022). Quality of data from cancer registries in the Eastern Mediterranean region. Lancet Oncology. 23(4): 449-451. PMID: 35358450 https://doi.org/10.1016/S1470-2045(22)00072-9        
  49. Andersson, T. M., Myklebust, T. A., Rutherford, M. J., Moller, B., Arnold, M., Soerjomataram, I., . . . Lambert, P. C. (2022). Five ways to improve international comparisons of cancer survival: lessons learned from ICBP SURVMARK-2. British Journal of Cancer. 126(8): 1224-1228. PMID: 35058590 https://doi.org/10.1038/s41416-022-01701-0               
  50. Andersson, T. M., Rutherford, M. J., Myklebust, T. A., Moller, B., Arnold, M., Soerjomataram, I., . . . Lambert, P. C. (2022). A way to explore the existence of “immortals” in cancer registry data – An illustration using data from ICBP SURVMARK-2. Cancer Epidemiology. 76: 102085. PMID: 34954495 https://doi.org/10.1016/j.canep.2021.102085    
  51. Araghi, M., Fidler-Benaoudia, M., Arnold, M., Rutherford, M., Bardot, A., Ferlay, J., . . . lung, I. C. C. L. c. C. (2022). International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study. Thorax. 77(4): 378-390. PMID: 34282033 https://doi.org/10.1136/thoraxjnl-2020-216555          
  52. Arnold, M., Morgan, E., Bardot, A., Rutherford, M. J., Ferlay, J., Little, A., . . . Soerjomataram, I. (2022). International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study). Gut. 71(8): 1532-1543. PMID: 34824149 https://doi.org/10.1136/gutjnl-2021-325266      
  53. Arnold, M., Morgan, E., Rumgay, H., Mafra, A., Singh, D., Laversanne, M., . . . Soerjomataram, I. (2022). Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 66: 15-23. PMID: 36084384 https://doi.org/10.1016/j.breast.2022.08.010    
  54. Arnold, M., Morgan, E., Rumgay, H., Mafra, A., Singh, D., Laversanne, M., . . . Soerjomataram, I. (2022). Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 66: 15-23. PMID: 36084384 https://doi.org/10.1016/j.breast.2022.08.010    
  55. Arnold, M., Singh, D., Laversanne, M., Vignat, J., Vaccarella, S., Meheus, F., . . . Bray, F. (2022). Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. JAMA Dermatol. 158(5): 495-503. PMID: 35353115 https://doi.org/10.1001/jamadermatol.2022.0160           
  56. Banack, H. R., Chang, J., Stefanick, M. L., Arnold, M., Anton-Culver, H., & Jiang, L. (2022). Relationship between BMI trajectories and cardiometabolic outcomes in postmenopausal women: a growth mixture modeling approach. Annals of Epidemiology. 72: 9-17. PMID: 35469929 https://doi.org/10.1016/j.annepidem.2022.04.004          
  57. Bravo, L. E., Garcia, L. S., Collazos, P., Holguin, J., Soerjomataram, I., & Miranda-Filho, A. (2022). Trends in long-term cancer survival in Cali, Colombia: 1998-2017. Colomb Med (Cali). 53(1): e2035082. PMID: 36452118 https://doi.org/10.25100/cm.v53i1.5082             
  58. Bravo, L. E., Garcia, L. S., Collazos, P., Holguin, J., Soerjomataram, I., & Miranda-Filho, A. (2022). Trends in long-term cancer survival in Cali, Colombia: 1998-2017. Colomb Med (Cali). 53(1): e2035082. PMID: 36452118 https://doi.org/10.25100/cm.v53i1.5082             
  59. Bray, F., Parkin, D. M., & African Cancer Registry, N. (2022). Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs. Lancet Oncology. 23(6): 719-728. PMID: 35550275 https://doi.org/10.1016/S1470-2045(22)00270-4             
  60. Bukavina, L., Bensalah, K., Bray, F., Carlo, M., Challacombe, B., Karam, J. A., . . . Psutka, S. P. (2022). Epidemiology of Renal Cell Carcinoma: 2022 Update. European Urology. 82(5): 529-542. PMID: 36100483 https://doi.org/10.1016/j.eururo.2022.08.019
  61. Byrne, J., Schmidtmann, I., Rashid, H., Hagberg, O., Bagnasco, F., Bardi, E., . . . Grabow, D. (2022). Impact of era of diagnosis on cause-specific late mortality among 77 423 five-year European survivors of childhood and adolescent cancer: The PanCareSurFup consortium. International Journal of Cancer. 150(3): 406-419. PMID: 34551126 https://doi.org/10.1002/ijc.33817           
  62. Cabasag, C. J., Arnold, M., Rutherford, M., Bardot, A., Ferlay, J., Morgan, E., . . . Soerjomataram, I. (2022). Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study. British Journal of Cancer. 126(12): 1774-1782. PMID: 35236937 https://doi.org/10.1038/s41416-022-01752-3              
  63. Cabasag, C. J., Fagan, P. J., Ferlay, J., Vignat, J., Laversanne, M., Liu, L., . . . Soerjomataram, I. (2022). Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020. International Journal of Cancer. 151(9): 1535-1541. PMID: 35322413 https://doi.org/10.1002/ijc.34002  
  64. Cabasag, C. J., Ferlay, J., Laversanne, M., Vignat, J., Weber, A., Soerjomataram, I., & Bray, F. (2022). Pancreatic cancer: an increasing global public health concern. Gut. 71(8): 1686-1687. PMID: 34686577 https://doi.org/10.1136/gutjnl-2021-326311  
  65. Cabasag, C. J., Vignat, J., Ferlay, J., Arndt, V., Lemmens, V., Praagman, J., . . . Soerjomataram, I. (2022). The preventability of cancer in Europe: A quantitative assessment of avoidable cancer cases across 17 cancer sites and 38 countries in 2020. European Journal of Cancer. 177: 15-24. PMID: 36323048 https://doi.org/10.1016/j.ejca.2022.09.030         
  66. Carle, C., Hughes, S., Freeman, V., Campbell, D., Egger, S., Caruana, M., . . . Steinberg, J. (2022). The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: A systematic review of the early evidence. J Cancer Policy. 33: 100338. PMID: 35671919 https://doi.org/10.1016/j.jcpo.2022.100338  
  67. Chargari, C., Arbyn, M., Leary, A., Abu-Rustum, N. R., Basu, P., Bray, F., . . . Morice, P. (2022). Increasing global accessibility to high-level treatments for cervical cancers. Gynecologic Oncology. 164(1): 231-241. PMID: 34716024 https://doi.org/10.1016/j.ygyno.2021.10.073     
  68. Charvat, H., Freisling, H., Noh, H., Gaudet, M. M., Gunter, M. J., Cross, A. J., . . . Arnold, M. (2022). Excess Body Fatness during Early to Mid-Adulthood and Survival from Colorectal and Breast Cancer: A Pooled Analysis of Five International Cohort Studies. Cancer Epidemiology, Biomarkers and Prevention. 31(2): 325-333. PMID: 34782393 https://doi.org/10.1158/1055-9965.EPI-21-0688              
  69. de Camargo Cancela, M., de Oliveira Santos, M., Migowski, A., & Pineros, M. (2022). Breast cancer among young women in Brazil: Differences between hospital and population-based series. Cancer Epidemiology. 79: 102193. PMID: 35696767 https://doi.org/10.1016/j.canep.2022.102193    
  70. Dee, E. C., Eala, M. A. B., Chua, M. L. K., Bray, F., & Bhoo-Pathy, N. (2022). Adolescents and young adults with cancer: Considerations from the Southeast Asian perspective. Pediatric Blood & Cancer. 69(7): e29593. PMID: 35129873 https://doi.org/10.1002/pbc.29593        
  71. Dee, E. C., Santos, P. M. G., & Bray, F. (2022). The shifting epidemiology of lung cancer in Asian and Asian diaspora populations: Implications for clinical and global health policy research. Asia-Pacific Journal of Clinical Oncology. 18(5): e524-e525. PMID: 35098661 https://doi.org/10.1111/ajco.13738   
  72. Doganis, D., Karalexi, M. A., group, N.-S. c., Panagopoulou, P., Bouka, P., Bouka, E., . . . Petridou, E. T. (2022). Incidence patterns of childhood non-Wilms renal tumors: Comparing data of the Nationwide Registry of Childhood Hematological Malignancies and Solid Tumors (NARECHEM-ST), Greece, and the Surveillance, Epidemiology, and End Results Program (SEER), USA. Cancer Epidemiology. 78: 102153. PMID: 35390585 https://doi.org/10.1016/j.canep.2022.102153
  73. Freeman, V., Hughes, S., Carle, C., Campbell, D., Egger, S., Hui, H., . . . Canfell, K. (2022). Are patients with cancer at higher risk of COVID-19-related death? A systematic review and critical appraisal of the early evidence. J Cancer Policy. 33: 100340. PMID: 35680113 https://doi.org/10.1016/j.jcpo.2022.100340  
  74. Gil, F., Miranda-Filho, A., Uribe-Perez, C., Arias-Ortiz, N. E., Yepez-Chamorro, M. C., Bravo, L. M., & de Vries, E. (2022). Impact of the Management and Proportion of Lost to Follow-Up Cases on Cancer Survival Estimates for Small Population-Based Cancer Registries. Journal of Cancer Epidemiology. 2022: 9068214. PMID: 35140789 https://doi.org/10.1155/2022/9068214
  75. Gini, A., & Selby, K. (2022). Fecal Immunochemical Tests: The Right Colorectal Cancer Screening Test for the Average-Risk Population? Clinical Gastroenterology and Hepatology. 20(10): 2216-2217. PMID: 35390510 https://doi.org/10.1016/j.cgh.2022.03.030          
  76. Guida, F., Kidman, R., Ferlay, J., Schuz, J., Soerjomataram, I., Kithaka, B., . . . McCormack, V. (2022). Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nature Medicine. 28(12): 2563-2572. PMID: 36404355 https://doi.org/10.1038/s41591-022-02109-2    
  77. Hanly, P., Ortega-Ortega, M., & Soerjomataram, I. (2022). Cancer Premature Mortality Costs in Europe in 2020: A Comparison of the Human Capital Approach and the Friction Cost Approach. Current Oncology (Toronto, Ont.). 29(5): 3552-3564. PMID: 35621677 https://doi.org/10.3390/curroncol29050287  
  78. Ibrahim Khalil, A., Franceschi, S., de Martel, C., Bray, F., & Clifford, G. M. (2022). Burden of Kaposi sarcoma according to HIV status: A systematic review and global analysis. International Journal of Cancer. 150(12): 1948-1957. PMID: 35085400 https://doi.org/10.1002/ijc.33951           
  79. Ibrahim Khalil, A., Mpunga, T., Wei, F., Baussano, I., de Martel, C., Bray, F., . . . Clifford, G. M. (2022). Age-specific burden of cervical cancer associated with HIV: A global analysis with a focus on sub-Saharan Africa. International Journal of Cancer. 150(5): 761-772. PMID: 34626498 https://doi.org/10.1002/ijc.33841         
  80. Ilbawi, A. M., Lam, C. G., Ortiz, R., & Bray, F. (2022). Investing in childhood cancer registries to drive progress. Lancet Child Adolesc Health. 6(7): 446-447. PMID: 35605627 https://doi.org/10.1016/S2352-4642(22)00148-1             
  81. Kenessey, I., Szoke, G., Dobozi, M., Szatmari, I., Weber, A., Fogarassy, G., . . . Vathy-Fogarassy, A. (2022). Comparison of Cancer Survival Trends in Hungary in the Periods 2001-2005 and 2011-2015 According to a Population-Based Cancer Registry. Pathology Oncology Research. 28: 1610668. PMID: 36147657 https://doi.org/10.3389/pore.2022.1610668      
  82. Kiss, Z., Wittmann, I., Polivka, L., Surjan, G., Surjan, O., Barcza, Z., . . . Voko, Z. (2022). Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study). Frontiers in Immunology. 13: 905585. PMID: 35812442 https://doi.org/10.3389/fimmu.2022.905585     
  83. Kiss, Z. N., Bogos, K., Tamasi, L., Ostoros, G., Muller, V., Bittner, N., . . . Polanyi, Z. (2022). Underlying reasons for post-mortem diagnosed lung cancer cases – A robust retrospective comparative study from Hungary (HULC study). Frontiers in Oncology. 12: 1032366. PMID: 36505881 https://doi.org/10.3389/fonc.2022.1032366         
  84. Kohls, M., Freisling, H., Charvat, H., Soerjomataram, I., Viallon, V., Davila-Batista, V., . . . Arnold, M. (2022). Impact of cumulative body mass index and cardiometabolic diseases on survival among patients with colorectal and breast cancer: a multi-centre cohort study. BMC Cancer. 22(1): 546. PMID: 35568802 https://doi.org/10.1186/s12885-022-09589-y    
  85. Leal, Y. A., Torres, J., Gamboa, R., Mantilla-Morales, A., Pina-Sanchez, P., Arrieta, O., . . . Pineros, M. (2022). Cancer Incidence in Merida, Mexico 2015-2018: First Report from the Population-based Cancer Registry. Archives of Medical Research. 53(8): 859-866. PMID: 36462950 https://doi.org/10.1016/j.arcmed.2022.11.015            
  86. Li, M., Zhang, L., Charvat, H., Callister, M. E., Sasieni, P., Christodoulou, E., . . . Robbins, H. A. (2022). The influence of postscreening follow-up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials. International Journal of Cancer. 151(9): 1491-1501. PMID: 35809038 https://doi.org/10.1002/ijc.34167           
  87. Lorenzoni, V., Chaturvedi, A. K., Vignat, J., Laversanne, M., Bray, F., & Vaccarella, S. (2022). The Current Burden of Oropharyngeal Cancer: A Global Assessment Based on GLOBOCAN 2020. Cancer Epidemiology, Biomarkers and Prevention. 31(11): 2054-2062. PMID: 36173880 https://doi.org/10.1158/1055-9965.EPI-22-0642
  88. Luo, Q., Lew, J. B., Steinberg, J., Worthington, J., Yu, X. Q., Caruana, M., . . . Feletto, E. (2022). Trends in colon and rectal cancer mortality in Australia from 1972 to 2015 and associated projections to 2040. Scientific Reports. 12(1): 3994. PMID: 35256697 https://doi.org/10.1038/s41598-022-07797-x     
  89. Luo, Q., O’Connell, D. L., Yu, X. Q., Kahn, C., Caruana, M., Pesola, F., . . . Canfell, K. (2022). Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study. Lancet Public Health. 7(6): e537-e548. PMID: 35660215 https://doi.org/10.1016/S2468-2667(22)00090-1             
  90. Mafra, A., Laversanne, M., Gospodarowicz, M., Klinger, P., De Paula Silva, N., Pineros, M., . . . Znaor, A. (2022). Global patterns of non-Hodgkin lymphoma in 2020. International Journal of Cancer. 151(9): 1474-1481. PMID: 35695282 https://doi.org/10.1002/ijc.34163           
  91. Mafra da Costa, A., Hernandes, I. C. P., Weiderpass, E., Soerjomataram, I., & Fregnani, J. (2022). Cancer Statistics over Time in Northwestern Sao Paulo State, Brazil: Incidence and Mortality. Cancer Epidemiology, Biomarkers and Prevention. 31(4): 707-714. PMID: 35131883 https://doi.org/10.1158/1055-9965.EPI-21-0842         
  92. Malakova, K., Cabasag, C. J., Bardot, A., Sangrajrang, S., Chitapanarux, I., Sripan, P., . . . Soerjomataram, I. (2022). Cancer survival in Thailand from 1997 to 2012: Assessing the impact of universal health coverage. J Cancer Policy. 34: 100353. PMID: 36357312 https://doi.org/10.1016/j.jcpo.2022.100353  
  93. Morgan, E., Arnold, M., Camargo, M. C., Gini, A., Kunzmann, A. T., Matsuda, T., . . . Soerjomataram, I. (2022). The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study. EClinicalMedicine. 47: 101404. PMID: 35497064 https://doi.org/10.1016/j.eclinm.2022.101404   
  94. Morgan, E., Soerjomataram, I., Rumgay, H., Coleman, H. G., Thrift, A. P., Vignat, J., . . . Arnold, M. (2022). The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020. Gastroenterology. 163(3): 649-658 e642. PMID: 35671803 https://doi.org/10.1053/j.gastro.2022.05.054      
  95. Nemati, S., Saeedi, E., Lotfi, F., Nahvijou, A., Mohebbi, E., Ravankhah, Z., . . . Zendehdel, K. (2022). National surveillance of cancer survival in Iran (IRANCANSURV): Analysis of data of 15 cancer sites from nine population-based cancer registries. International Journal of Cancer. 151(12): 2128-2135. PMID: 35869869 https://doi.org/10.1002/ijc.34224           
  96. Nemati, S., Saeedi, E., Roshandel, G., Nahvijou, A., Badakhshan, A., Akbari, M., . . . Zendehdel, K. (2022). Population-based cancer survival in the Golestan province in the northeastern part of Iran 2007-2012. Cancer Epidemiology. 77: 102089. PMID: 35042146 https://doi.org/10.1016/j.canep.2021.102089              
  97. Noll, F., Adams, T., Cohen, R., Soerjomataram, I., & Reid, F. (2022). Building opportunities to improve quality of life for women with ovarian cancer in low- and middle-income countries: the Every Woman Study. International Journal of Gynecological Cancer. 32(8): 1080-1081. PMID: 35314459 https://doi.org/10.1136/ijgc-2022-003449    
  98. Ortega-Ortega, M., Hanly, P., Pearce, A., Soerjomataram, I., & Sharp, L. (2022). Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018. International Journal of Cancer. 150(4): 580-593. PMID: 34569617 https://doi.org/10.1002/ijc.33826           
  99. Pastorino, R., Sassano, M., Danilo Tiziano, F., Giraldi, L., Amore, R., Arzani, D., . . . Boccia, S. (2022). Plasma miR-151-3p as a Candidate Diagnostic Biomarker for Head and Neck Cancer: A Cross-sectional Study within the INHANCE Consortium. Cancer Epidemiology, Biomarkers and Prevention. 31(12): 2237-2243. PMID: 36126276 https://doi.org/10.1158/1055-9965.EPI-22-0376              
  100. Payne, N. W. S., Brown, K. F., Delon, C., Kotrotsios, Y., Soerjomataram, I., & Shelton, J. (2022). Socio-economic deprivation and cancer incidence in England: Quantifying the role of smoking. PloS One. 17(9): e0272202. PMID: 36129905 https://doi.org/10.1371/journal.pone.0272202
  101. Persson, M. S. M., Yin, W., Doring, N., Risnes, K., Weiderpass, E., Steliarova-Foucher, E., & Sandin, S. (2022). Gestational age and cancer risk up to young adulthood in Swedish population born 1974 to 2013: A population-based cohort study. International Journal of Cancer. 150(8): 1269-1280. PMID: 34855204 https://doi.org/10.1002/ijc.33886           
  102. Pierannunzio, D., Fedeli, U., Francisci, S., Paoli, A., Toffolutti, F., Serraino, D., . . . Dal Maso, L. (2022). Thyroidectomies in Italy: A Population-Based National Analysis from 2001 to 2018. Thyroid. 32(3): 263-272. PMID: 35018816 https://doi.org/10.1089/thy.2021.0531
  103. Pilleron, S., Alqurini, N., Ferlay, J., Haase, K. R., Hannan, M., Janssen-Heijnen, M., . . . Morris, E. J. A. (2022). International trends in cancer incidence in middle-aged and older adults in 44 countries. Journal of Geriatric Oncology. 13(3): 346-355. PMID: 34866023 https://doi.org/10.1016/j.jgo.2021.11.011      
  104. Pinello, K., Baldassarre, V., Steiger, K., Paciello, O., Pires, I., Laufer-Amorim, R., . . . Dagli, M. L. Z. (2022). Vet-ICD-O-Canine-1, a System for Coding Canine Neoplasms Based on the Human ICD-O-3.2. Cancers. 14(6). PMID: 35326681 https://doi.org/10.3390/cancers14061529          
  105. Pineros, M. (2022). Evaluation and variability of quality in mortality statistics in Colombia: the importance of detail. REVISTA COLOMBIANA DE CANCEROLOGIA. 26(3): 241-243. PMID:   
  106. Pineros, M., Ginsburg, O., Bendahhou, K., Eser, S., Shelpai, W. A., Fouad, H., . . . Staging Survey, G. (2022). Staging practices and breast cancer stage among population-based registries in the MENA region. Cancer Epidemiology. 81: 102250. PMID: 36115143 https://doi.org/10.1016/j.canep.2022.102250              
  107. Pineros, M., Laversanne, M., Barrios, E., Cancela, M. C., de Vries, E., Pardo, C., & Bray, F. (2022). An updated profile of the cancer burden, patterns and trends in Latin America and the Caribbean. Lancet Reg Health Am. 13: None. PMID: 36189115 https://doi.org/10.1016/j.lana.2022.100294       
  108. Pizzato, M., Li, M., Vignat, J., Laversanne, M., Singh, D., La Vecchia, C., & Vaccarella, S. (2022). The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes and Endocrinology. 10(4): 264-272. PMID: 35271818 https://doi.org/10.1016/S2213-8587(22)00035-3            
  109. Pizzato, M., Martinsen, J. I., Heikkinen, S., Vignat, J., Lynge, E., Sparen, P., . . . Vaccarella, S. (2022). Socioeconomic status and risk of lung cancer by histological subtype in the Nordic countries. Cancer Med. 11(8): 1850-1859. PMID: 35166068 https://doi.org/10.1002/cam4.4548       
  110. Roel, E., Pistillo, A., Recalde, M., Fernandez-Bertolin, S., Aragon, M., Soerjomataram, I., . . . Duarte-Salles, T. (2022). Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: A population-based multistate cohort study including 4 618 377 adults in Catalonia, Spain. International Journal of Cancer. 150(5): 782-794. PMID: 34655476 https://doi.org/10.1002/ijc.33846         
  111. Rumgay, H., Arnold, M., Ferlay, J., Lesi, O., Cabasag, C. J., Vignat, J., . . . Soerjomataram, I. (2022). Global burden of primary liver cancer in 2020 and predictions to 2040. Journal of Hepatology. 77(6): 1598-1606. PMID: 36208844 https://doi.org/10.1016/j.jhep.2022.08.021        
  112. Rumgay, H., Ferlay, J., de Martel, C., Georges, D., Ibrahim, A. S., Zheng, R., . . . Soerjomataram, I. (2022). Global, regional and national burden of primary liver cancer by subtype. European Journal of Cancer. 161: 108-118. PMID: 34942552 https://doi.org/10.1016/j.ejca.2021.11.023         
  113. Sarich, P., Cabasag, C. J., Liebermann, E., Vaneckova, P., Carle, C., Hughes, S., . . . Soerjomataram, I. (2022). Tobacco smoking changes during the first pre-vaccination phases of the COVID-19 pandemic: A systematic review and meta-analysis. EClinicalMedicine. 47: 101375. PMID: 35434579 https://doi.org/10.1016/j.eclinm.2022.101375   
  114. Singh, D., Vaccarella, S., Gini, A., De Paula Silva, N., Steliarova-Foucher, E., & Bray, F. (2022). Global patterns of Hodgkin lymphoma incidence and mortality in 2020 and a prediction of the future burden in 2040. International Journal of Cancer. 150(12): 1941-1947. PMID: 35080783 https://doi.org/10.1002/ijc.33948
  115. Smith, L., Stiller, C. A., Aitken, J. F., Hjalgrim, L. L., Johannesen, T., Lahteenmaki, P., . . . Feltbower, R. G. (2022). International variation in childhood cancer mortality rates from 2001 to 2015: Comparison of trends in the International Cancer Benchmarking Partnership countries. International Journal of Cancer. 150(1): 28-37. PMID: 34449879 https://doi.org/10.1002/ijc.33774      
  116. Soerjomataram, I., Bardot, A., Aitken, J., Pineros, M., Znaor, A., Steliarova-Foucher, E., . . . Bray, F. (2022). Impact of the COVID-19 pandemic on population-based cancer registry. International Journal of Cancer. 150(2): 273-278. PMID: 34480348 https://doi.org/10.1002/ijc.33792           
  117. Soerjomataram, I., Bray, F., Lansdorp-Vogelaar, I., Ginsburg, O., Rahal, R., Sullivan, R., . . . Cancer Global Modelling, C. (2022). COVID-19 and Cancer Global Modelling Consortium (CCGMC): A global reference to inform national recovery strategies. J Cancer Policy. 32: 100328. PMID: 35560265 https://doi.org/10.1016/j.jcpo.2022.100328       
  118. Soo, R., Mery, L., Bardot, A., Kanesvaran, R., Keong, T. C., Pongnikorn, D., . . . Stahel, R. (2022). Diagnostic work-up and systemic treatment for advanced non-squamous non-small-cell lung cancer in four Southeast Asian countries. ESMO Open. 7(5): 100560. PMID: 35988454 https://doi.org/10.1016/j.esmoop.2022.100560           
  119. Voko, Z., Kiss, Z., Surjan, G., Surjan, O., Barcza, Z., Wittmann, I., . . . Kasler, M. (2022). Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study). Frontiers in Immunology. 13: 919408. PMID: 35935993 https://doi.org/10.3389/fimmu.2022.919408     
  120. Wang, S., Zheng, R., Arnold, M., Abnet, C., Zeng, H., Zhang, S., . . . He, J. (2022). Global and national trends in the age-specific sex ratio of esophageal cancer and gastric cancer by subtype. International Journal of Cancer. 151(9): 1447-1461. PMID: 35678331 https://doi.org/10.1002/ijc.34158           
  121. Weber, A., Szatmari, I., Dobozi, M., Hilbert, L., Branyiczkine Geczy, G., Nagy, P., . . . Kenessey, I. (2022). [Comparison of Hungarian Central Statistical Office’s causes of death data with the database of the Hungarian National Cancer Registry]. Orvosi Hetilap. 163(37): 1481-1489. PMID: 36088625 https://doi.org/10.1556/650.2022.32573
  122. Withrow, D., Pilleron, S., Nikita, N., Ferlay, J., Sharma, S., Nicholson, B., . . . Lu-Yao, G. (2022). Current and projected number of years of life lost due to prostate cancer: A global study. Prostate. 82(11): 1088-1097. PMID: 35468227 https://doi.org/10.1002/pros.24360       
  123. Znaor, A., Corbex, M., Cao, B., Laversanne, M., Ryzhov, A., Smelov, V., & Bray, F. (2022). Progress in reducing premature mortality from cancer and cardiovascular disease in the former Soviet Union, 2000-19. European Journal of Public Health. 32(4): 624-629. PMID: 35441219 https://doi.org/10.1093/eurpub/ckac030
  124. Znaor, A., Skakkebaek, N. E., Rajpert-De Meyts, E., Kulis, T., Laversanne, M., Gurney, J., . . . Bray, F. (2022). Global patterns in testicular cancer incidence and mortality in 2020. International Journal of Cancer. 151(5): 692-698. PMID: 35277970 https://doi.org/10.1002/ijc.33999           
  125. Amosa-Lei Sam, F., Akinremi, A., Mery, L., Sarfati, D., Stanley, J., & Gurney, J. (2021). Cancer Incidence in Samoa: A 10-Year Retrospective Survey (2007-2016). Asia Pac J Public Health. 33(6-7): 700-706. PMID: 33233921  doi: 10.1177/1010539520975261
  126. Andersson, T. M., Myklebust, T. A., Rutherford, M. J., Moller, B., Soerjomataram, I., Arnold, M., . . . Lambert, P. C. (2021). The impact of excluding or including Death Certificate Initiated (DCI) cases on estimated cancer survival: A simulation study. Cancer Epidemiol. 71(Pt A): 101881. PMID: 33440295  doi: 10.1016/j.canep.2020.101881
  127. Andersson, T. M., Rutherford, M. J., Myklebust, T. A., Moller, B., Soerjomataram, I., Arnold, M., . . . Lambert, P. C. (2021). Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study. Br J Cancer. 124(5): 1026-1032. PMID: 33293692  doi: 10.1038/s41416-020-01196-7
  128. Araghi, M., Arnold, M., Rutherford, M. J., Guren, M. G., Cabasag, C. J., Bardot, A., . . . Soerjomataram, I. (2021). Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project). Gut. 70(1): 114-126. PMID: 32482683  doi: 10.1136/gutjnl-2020-320625
  129. Arbyn, M., Gultekin, M., Morice, P., Nieminen, P., Cruickshank, M., Poortmans, P., . . . Weiderpass, E. (2021). The European response to the WHO call to eliminate cervical cancer as a public health problem. Int J Cancer. 148(2): 277-284. PMID: 32638362  doi: 10.1002/ijc.33189
  130. Barchuk, A., Belyaev, A., Gretsova, O., Tursun-Zade, R., Moshina, N., & Znaor, A. (2021). History and current status of cancer registration in Russia. Cancer Epidemiol. 73: 101963. PMID: 34089992  doi: 10.1016/j.canep.2021.101963
  131. Barchuk, A., Tursun-Zade, R., Belayev, A., Moore, M., Komarov, Y., Moshina, N., . . . Znaor, A. (2021). Comparability and validity of cancer registry data in the northwest of Russia. Acta Oncol. 60(10): 1264-1271. PMID: 34424113  doi: 10.1080/0284186X.2021.1967443
  132. Bonjour, M., Charvat, H., Franco, E. L., Pineros, M., Clifford, G. M., Bray, F., & Baussano, I. (2021). Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis. Lancet Public Health. 6(7): e510-e521. PMID: 33864738  doi: 10.1016/S2468-2667(21)00046-3
  133. Bray, F., Laversanne, M., Cao, B., Varghese, C., Mikkelsen, B., Weiderpass, E., & Soerjomataram, I. (2021). Comparing cancer and cardiovascular disease trends in 20 middle- or high-income countries 2000-19: A pointer to national trajectories towards achieving Sustainable Development goal target 3.4. Cancer Treat Rev. 100: 102290. PMID: 34536729  doi: 10.1016/j.ctrv.2021.102290
  134. Bray, F., Laversanne, M., Weiderpass, E., & Soerjomataram, I. (2021). The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 127(16): 3029-3030. PMID: 34086348  doi: 10.1002/cncr.33587
  135. Bukirwa, P., Wabinga, H., Nambooze, S., Amulen, P. M., Joko, W. Y., Liu, B., & Parkin, D. M. (2021). Trends in the incidence of cancer in Kampala, Uganda, 1991 to 2015. Int J Cancer. 148(9): 2129-2138. PMID: 33129228  doi: 10.1002/ijc.33373
  136. Cabasag, C. J., Arnold, M., Pineros, M., Morgan, E., Brierley, J., Hofferkamp, J., . . . Parkin, D. M. (2021). Population-based cancer staging for oesophageal, gastric, and pancreatic cancer 2012-2014: International Cancer Benchmarking Partnership SurvMark-2. Int J Cancer. 149(6): 1239-1246. PMID: 33990959  doi: 10.1002/ijc.33679
  137. Conway, D. I., Hovanec, J., Ahrens, W., Ross, A., Holcatova, I., Lagiou, P., . . . McMahon, A. D. (2021). Occupational socioeconomic risk associations for head and neck cancer in Europe and South America: individual participant data analysis of pooled case-control studies within the INHANCE Consortium. J Epidemiol Community Health. 75(8): 779-787. PMID: 33622804  doi: 10.1136/jech-2020-214913
  138. Crocetti, E., Mattioli, V., Buzzoni, C., Franceschi, S., Serraino, D., Vaccarella, S., . . . for, A. w. g. (2021). Risk of thyroid as a first or second primary cancer. A population-based study in Italy, 1998-2012. Cancer Med. 10(19): 6855-6867. PMID: 34533289  doi: 10.1002/cam4.4193
  139. Dal Maso, L., Panato, C., De Paoli, A., Mattioli, V., Serraino, D., Elisei, R., . . . Group, D. W. (2021). Trends in thyroid function testing, neck ultrasound, thyroid fine needle aspiration, and thyroidectomies in North-eastern Italy. J Endocrinol Invest. 44(8): 1679-1688. PMID: 33460012  doi: 10.1007/s40618-020-01475-3
  140. Duggan, C., Trapani, D., Ilbawi, A. M., Fidarova, E., Laversanne, M., Curigliano, G., . . . Anderson, B. O. (2021). National health system characteristics, breast cancer stage at diagnosis, and breast cancer mortality: a population-based analysis. Lancet Oncol. 22(11): 1632-1642. PMID: 34653370  doi: 10.1016/S1470-2045(21)00462-9
  141. Dyba, T., Randi, G., Bray, F., Martos, C., Giusti, F., Nicholson, N., . . . Bettio, M. (2021). The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer. 157: 308-347. PMID: 34560371  doi: 10.1016/j.ejca.2021.07.039
  142. Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Pineros, M., Znaor, A., & Bray, F. (2021). Cancer statistics for the year 2020: An overview. Int J Cancer. 149(4): 778-789. PMID: 33818764  doi: 10.1002/ijc.33588
  143. Gandaglia, G., Leni, R., Bray, F., Fleshner, N., Freedland, S. J., Kibel, A., . . . La Vecchia, C. (2021). Epidemiology and Prevention of Prostate Cancer. Eur Urol Oncol. 4(6): 877-892. PMID: 34716119  doi: 10.1016/j.euo.2021.09.006
  144. Genere, N., El Kawkgi, O. M., Giblon, R. E., Vaccarella, S., Morris, J. C., Hay, I. D., & Brito, J. P. (2021). Incidence of Clinically Relevant Thyroid Cancers Remains Stable for Almost a Century: A Population-Based Study. Mayo Clin Proc. 96(11): 2823-2830. PMID: 34736609  doi: 10.1016/j.mayocp.2021.04.028
  145. Gredner, T., Mons, U., Niedermaier, T., Brenner, H., & Soerjomataram, I. (2021). Impact of tobacco control policies implementation on future lung cancer incidence in Europe: An international, population-based modeling study. Lancet Reg Health Eur. 4: 100074. PMID: 34029359  doi: 10.1016/j.lanepe.2021.100074
  146. Gullickson, C., Goodman, M., Joko-Fru, Y. W., Gnangnon, F. H. R., N’Da, G., Woldegeorgis, M. A., . . . Jemal, A. (2021). Colorectal cancer survival in sub-Saharan Africa by age, stage at diagnosis and Human Development Index: A population-based registry study. Int J Cancer. 149(8): 1553-1563. PMID: 34164808  doi: 10.1002/ijc.33715
  147. Johnson, S., Tittenbrun, Z., Romero, Y., Torode, J., Frech, S., Abdel-Wahab, M., . . . Mikkelsen, B. (2021). The World Cancer Declaration: time to consolidate wins and work towards 2025. Lancet Oncol. 22(3): 296-298. PMID: 33548178  doi: 10.1016/S1470-2045(21)00012-7
  148. Johnston, W. T., Erdmann, F., Newton, R., Steliarova-Foucher, E., Schuz, J., & Roman, E. (2021). Childhood cancer: Estimating regional and global incidence. Cancer Epidemiol. 71(Pt B): 101662. PMID: 31924557  doi: 10.1016/j.canep.2019.101662
  149. Kilian, C., Rovira, P., Neufeld, M., Ferreira-Borges, C., Rumgay, H., Soerjomataram, I., & Rehm, J. (2021). Modelling the impact of increased alcohol taxation on alcohol-attributable cancers in the WHO European Region. Lancet Reg Health Eur. 11: 100225. PMID: 34918000  doi: 10.1016/j.lanepe.2021.100225
  150. Li, M., Delafosse, P., Meheus, F., Borson-Chazot, F., Lifante, J. C., Simon, R., . . . Thyroid Cancer Group, F. (2021). Temporal and geographical variations of thyroid cancer incidence and mortality in France during 1986-2015: The impact of overdiagnosis. Cancer Epidemiol. 75: 102051. PMID: 34743057  doi: 10.1016/j.canep.2021.102051
  151. Li, M., Zheng, R., Dal Maso, L., Zhang, S., Wei, W., & Vaccarella, S. (2021). Mapping overdiagnosis of thyroid cancer in China. Lancet Diabetes Endocrinol. 9(6): 330-332. PMID: 33891886  doi: 10.1016/S2213-8587(21)00083-8
  152. Liu, B., Youlden, D. R., Wabinga, H., Nambooze, S., Amulen, P. M., Aitken, J. F., & Parkin, D. M. (2021). Survival from childhood cancer in Kampala, Uganda. Pediatr Blood Cancer. 68(3): e28876. PMID: 33381877  doi: 10.1002/pbc.28876
  153. Longatto-Filho, A., Fregnani, J. H., Mafra da Costa, A., de Araujo-Souza, P. S., Scapulatempo-Neto, C., Herbster, S., . . . Termini, L. (2021). Evaluation of Elafin Immunohistochemical Expression as Marker of Cervical Cancer Severity. Acta Cytol. 65(2): 165-174. PMID: 33271565  doi: 10.1159/000512010
  154. Mafra da Costa, A., Ribeiro, A. L., Ribeiro, A. G., Gini, A., Cabasag, C., Reis, R. M., . . . Soerjomataram, I. (2021). Impact of COVID-19 Pandemic on Cancer-Related Hospitalizations in Brazil. Cancer Control. 28: 10732748211038736. PMID: 34406894  doi: 10.1177/10732748211038736
  155. Mandrik, O., Tolma, E., Zielonke, N., Meheus, F., Ordonez-Reyes, C., Severens, J. L., & Murillo, R. (2021). Systematic reviews as a “lens of evidence”: Determinants of participation in breast cancer screening. J Med Screen. 28(2): 70-79. PMID: 32517538  doi: 10.1177/0969141320930743
  156. Marant Micallef, C., Paul, A., Charvat, H., Vignat, J., Houot, M., Pilorget, C., . . . Soerjomataram, I. (2021). An innovative method to estimate lifetime prevalence of carcinogenic occupational circumstances: the example of painters and workers of the rubber manufacturing industry in France. J Expo Sci Environ Epidemiol. 31(4): 769-776. PMID: 33144638  doi: 10.1038/s41370-020-00272-7
  157. Miranda-Filho, A., Charvat, H., Bray, F., Migowski, A., Cheung, L. C., Vaccarella, S., . . . Robbins, H. A. (2021). A modeling analysis to compare eligibility strategies for lung cancer screening in Brazil. EClinicalMedicine. 42: 101176. PMID: 34765952  doi: 10.1016/j.eclinm.2021.101176
  158. Miranda-Filho, A., Lortet-Tieulent, J., Bray, F., Cao, B., Franceschi, S., Vaccarella, S., & Dal Maso, L. (2021). Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 9(4): 225-234. PMID: 33662333  doi: 10.1016/S2213-8587(21)00027-9
  159. Morgan, E., Arnold, M., Rutherford, M. J., Bardot, A., Ferlay, J., De, P., . . . Soerjomataram, I. (2021). The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non-small cell lung cancer (ICBP SurvMark-2 project). Int J Cancer. 149(5): 1013-1020. PMID: 33932300  doi: 10.1002/ijc.33620
  160. Morgan, E., Soerjomataram, I., Gavin, A. T., Rutherford, M. J., Gatenby, P., Bardot, A., . . . Arnold, M. (2021). International trends in oesophageal cancer survival by histological subtype between 1995 and 2014. Gut. 70(2): 234-242. PMID: 32554620  doi: 10.1136/gutjnl-2020-321089
  161. Musetti, C., Garau, M., Alonso, R., Pineros, M., Soerjomataram, I., & Barrios, E. (2021). Colorectal Cancer in Young and Older Adults in Uruguay: Changes in Recent Incidence and Mortality Trends. Int J Environ Res Public Health. 18(15): 8232. PMID: 34360522  doi: 10.3390/ijerph18158232
  162. Parkin, D. M., Chingonzoh, T., Vuma, S., Liu, B., Chokunonga, E., Ndlovu, N., & Borok, M. (2021). Changes in the Incidence of Cancer in Bulawayo, Zimbabwe over a 50-Year Period. Cancer Epidemiol Biomarkers Prev. 30(5): 867-873. PMID: 33619023  doi: 10.1158/1055-9965.EPI-20-0669
  163. Parkin, D. M., Youlden, D. R., Chitsike, I., Chokunonga, E., Couitchere, L., Gnahatin, F., . . . Aitken, J. F. (2021). Stage at diagnosis and survival by stage for the leading childhood cancers in three populations of sub-Saharan Africa. Int J Cancer. 148(11): 2685-2691. PMID: 33433927  doi: 10.1002/ijc.33468
  164. Perera, S. K., Jacob, S., Wilson, B. E., Ferlay, J., Bray, F., Sullivan, R., & Barton, M. (2021). Global demand for cancer surgery and an estimate of the optimal surgical and anaesthesia workforce between 2018 and 2040: a population-based modelling study. Lancet Oncol. 22(2): 182-189. PMID: 33485458  doi: 10.1016/S1470-2045(20)30675-6
  165. Pilleron, S., Charvat, H., Araghi, M., Arnold, M., Fidler-Benaoudia, M. M., Bardot, A., . . . Soerjomataram, I. (2021). Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study. Int J Cancer. 148(7): 1575-1585. PMID: 33006395  doi: 10.1002/ijc.33326
  166. Pilleron, S., Maringe, C., Charvat, H., Atkinson, J., Morris, E., & Sarfati, D. (2021). Age disparities in lung cancer survival in New Zealand: The role of patient and clinical factors. Lung Cancer. 157: 92-99. PMID: 34006378  doi: 10.1016/j.lungcan.2021.05.015
  167. Pilleron, S., Maringe, C., Charvat, H., Atkinson, J., Morris, E. J. A., & Sarfati, D. (2021). The impact of timely cancer diagnosis on age disparities in colon cancer survival. J Geriatr Oncol. 12(7): 1044-1051. PMID: 33863698  doi: 10.1016/j.jgo.2021.04.003
  168. Pilleron, S., Soto-Perez-de-Celis, E., Vignat, J., Ferlay, J., Soerjomataram, I., Bray, F., & Sarfati, D. (2021). Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050. Int J Cancer. 148(3): 601-608. PMID: 32706917  doi: 10.1002/ijc.33232
  169. Pineros, M., Abriata, M. G., de Vries, E., Barrios, E., Bravo, L. E., Cueva, P., . . . Mery, L. (2021). Progress, challenges and ways forward supporting cancer surveillance in Latin America. Int J Cancer. 149(1): 12-20. PMID: 33231289  doi: 10.1002/ijc.33407
  170. Pineros, M., Mery, L., Soerjomataram, I., Bray, F., & Steliarova-Foucher, E. (2021). Scaling Up the Surveillance of Childhood Cancer: A Global Roadmap. J Natl Cancer Inst. 113(1): 9-15. PMID: 32433739  doi: 10.1093/jnci/djaa069
  171. Pineros, M., Saraiya, M., Baussano, I., Bonjour, M., Chao, A., & Bray, F. (2021). The role and utility of population-based cancer registries in cervical cancer surveillance and control. Prev Med. 144: 106237. PMID: 33678223  doi: 10.1016/j.ypmed.2020.106237
  172. Puyol, M., Seoane, J., Aguilar, E., Vozza, L. B., Orbe, I., Crawford, K. H., . . . Gopal, S. (2021). WORLD CANCER RESEARCH DAY: A Call to Action for a Coordinated International Research Effort to Prevent, Diagnose, and Treat Cancer. Clin Cancer Res. 27(4): 963-966. PMID: 33257425  doi: 10.1158/1078-0432.CCR-20-2978
  173. Roel, E., Pistillo, A., Recalde, M., Sena, A. G., Fernandez-Bertolin, S., Aragon, M., . . . Duarte-Salles, T. (2021). Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain. Cancer Epidemiol Biomarkers Prev. 30(10): 1884-1894. PMID: 34272262  doi: 10.1158/1055-9965.EPI-21-0266
  174. Roshandel, G., Ferlay, J., Ghanbari-Motlagh, A., Partovipour, E., Salavati, F., Aryan, K., . . . Bray, F. (2021). Cancer in Iran 2008 to 2025: Recent incidence trends and short-term predictions of the future burden. Int J Cancer. 149(3): 594-605. PMID: 33884608  doi: 10.1002/ijc.33574
  175. Rovira, P., Kilian, C., Neufeld, M., Rumgay, H., Soerjomataram, I., Ferreira-Borges, C., . . . Rehm, J. (2021). Fewer Cancer Cases in 4 Countries of the WHO European Region in 2018 through Increased Alcohol Excise Taxation: A Modelling Study. Eur Addict Res. 27(3): 189-197. PMID: 33271557  doi: 10.1159/000511899
  176. Rumgay, H., Arnold, M., Laversanne, M., Whiteman, D. C., Thrift, A. P., Wei, W., . . . Soerjomataram, I. (2021). International Trends in Esophageal Squamous Cell Carcinoma and Adenocarcinoma Incidence. Am J Gastroenterol. 116(5): 1072-1076. PMID: 33929382  doi: 10.14309/ajg.0000000000001121
  177. Rumgay, H., Murphy, N., Ferrari, P., & Soerjomataram, I. (2021). Alcohol and Cancer: Epidemiology and Biological Mechanisms. Nutrients. 13(9). PMID: 34579050  doi: 10.3390/nu13093173
  178. Rumgay, H., Shield, K., Charvat, H., Ferrari, P., Sornpaisarn, B., Obot, I., . . . Soerjomataram, I. (2021). Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. Lancet Oncol. 22(8): 1071-1080. PMID: 34270924  doi: 10.1016/S1470-2045(21)00279-5
  179. Rutherford, M. J., Arnold, M., Bardot, A., Ferlay, J., De, P., Tervonen, H., . . . Soerjomataram, I. (2021). Comparison of liver cancer incidence and survival by subtypes across seven high-income countries. Int J Cancer. 149(12): 2020-2031. PMID: 34460109  doi: 10.1002/ijc.33767
  180. Ryzhov, A., Corbex, M., Pineros, M., Barchuk, A., Andreasyan, D., Djanklich, S., . . . Znaor, A. (2021). Comparison of breast cancer and cervical cancer stage distributions in ten newly independent states of the former Soviet Union: a population-based study. Lancet Oncol. 22(3): 361-369. PMID: 33556324  doi: 10.1016/S1470-2045(20)30674-4
  181. Seraphin, T. P., Joko-Fru, W. Y., Hammerl, L., Griesel, M., Mezger, N. C. S., Feuchtner, J. C., . . . Kantelhardt, E. J. (2021). Presentation, patterns of care, and outcomes of patients with prostate cancer in sub-Saharan Africa: A population-based registry study. Cancer. 127(22): 4221-4232. PMID: 34328216  doi: 10.1002/cncr.33818
  182. Seraphin, T. P., Joko-Fru, W. Y., Kamate, B., Chokunonga, E., Wabinga, H., Somdyala, N. I. M., . . . Parkin, D. M. (2021). Rising Prostate Cancer Incidence in Sub-Saharan Africa: A Trend Analysis of Data from the African Cancer Registry Network. Cancer Epidemiol Biomarkers Prev. 30(1): 158-165. PMID: 33033143  doi: 10.1158/1055-9965.EPI-20-1005
  183. Seraphin, T. P., Joko-Fru, W. Y., Manraj, S. S., Chokunonga, E., Somdyala, N. I. M., Korir, A., . . . Parkin, D. M. (2021). Prostate cancer survival in sub-Saharan Africa by age, stage at diagnosis, and human development index: a population-based registry study. Cancer Causes Control. 32(9): 1001-1019. PMID: 34244896  doi: 10.1007/s10552-021-01453-x
  184. Snijders, R., Fukinsia, A., Claeys, Y., Hasker, E., Mpanya, A., Miaka, E., . . . Boelaert, M. (2021). Costs and Outcomes of Integrated Human African Trypanosomiasis Surveillance System Using Rapid Diagnostic Tests, Democratic Republic of the Congo. Emerg Infect Dis. 27(8): 2144-2153. PMID: 34287133  doi: 10.3201/eid2708.202399
  185. Soerjomataram, I., & Bray, F. (2021). Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070. Nat Rev Clin Oncol. 18(10): 663-672. PMID: 34079102  doi: 10.1038/s41571-021-00514-z
  186. Soerjomataram, I., Ervik, M., Fox, C., Hawkins, S., Yeung, K., Napolitano, G., . . . Gavin, A. (2021). CanStaging+: an electronic staging tool for population-based cancer registries. Lancet Oncol. 22(8): 1069. PMID: 34339643  doi: 10.1016/S1470-2045(21)00188-1
  187. Stoeter, O., Seraphin, T. P., Chitsike, I., Chokunonga, E., Kambugu, J. B., Wabinga, H., . . . Kantelhardt, E. J. (2021). Trends in childhood cancer incidence in sub-Saharan Africa: Results from 25 years of cancer registration in Harare (Zimbabwe) and Kyadondo (Uganda). Int J Cancer. 149(5): 1002-1012. PMID: 33945631  doi: 10.1002/ijc.33619
  188. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 71(3): 209-249. PMID: 33538338  doi: 10.3322/caac.21660
  189. Vaccarella, S., & Dal Maso, L. (2021). Challenges in investigating risk factors for thyroid cancer. Lancet Diabetes Endocrinol. 9(2): 57-59. PMID: 33347808  doi: 10.1016/S2213-8587(20)30426-5
  190. Vaccarella, S., Ginsburg, O., & Bray, F. (2021). Gender inequalities in cancer among young adults. Lancet Oncol. 22(2): 166-167. PMID: 33539738  doi: 10.1016/S1470-2045(21)00001-2
  191. Vaccarella, S., Lortet-Tieulent, J., Colombet, M., Davies, L., Stiller, C. A., Schuz, J., . . . contributors, I.-. (2021). Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: a population-based study. Lancet Diabetes Endocrinol. 9(3): 144-152. PMID: 33482107  doi: 10.1016/S2213-8587(20)30401-0
  192. Yang, Z., Yang, J., Li, M. M., Chen, J. J., & Ou, C. Q. (2021). Nonlinear and lagged meteorological effects on daily levels of ambient PM2.5 and O-3: Evidence from 284 Chinese cities. J Clean Prod. 278: 10. doi: 10.1016/j.jclepro.2020.123931
  193. Znaor, A., Fouad, H., Majnoni d’Intignano, F., Hammerich, A., Slama, S., Pourghazian, N., . . . Bray, F. (2021). Use of cancer data for cancer control in the Eastern Mediterranean Region: Results of a survey among population-based cancer registries. Int J Cancer. 148(3): 593-600. PMID: 32683692  doi: 10.1002/ijc.33223
  194. Znaor, A., Ryzhov, A., Corbex, M., Pineros, M., & Bray, F. (2021). Cervical cancer in the Newly Independent States of the former Soviet Union: Incidence will remain high without action. Cancer Epidemiol. 73: 101944. PMID: 33975255  doi: 10.1016/j.canep.2021.101944
  195. Araghi, M., Roshandel, G., Hasanpour-Heidari, S., Fazel, A., Sedaghat, S. M., Pourkhani, A., . . . Arnold, M. (2020). Incidence of Malignant Brain and Central Nervous System Tumors in Golestan, Iran, 2004-2013. Arch Iran Med. 23(1): 1-6. PMID: 31910628
  196. Arbyn, M., Weiderpass, E., Bruni, L., de Sanjose, S., Saraiya, M., Ferlay, J., & Bray, F. (2020). Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 8(2): e191-e203. PMID: 31812369 doi: 10.1016/s2214-109x(19)30482-6
  197. Armaroli, P., Riggi, E., Basu, P., Anttila, A., Ponti, A., Carvalho, A. L., . . . Segnan, N. (2020). Performance indicators in breast cancer screening in the European Union: A comparison across countries of screen positivity and detection rates. Int J Cancer. 147(7): 1855-1863. PMID: 32159224 doi: 10.1002/ijc.32968
  198. Arnold, M., Abnet, C. C., Neale, R. E., Vignat, J., Giovannucci, E. L., McGlynn, K. A., & Bray, F. (2020). Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology. 159(1): 335-349 e315. PMID: 32247694 doi: 10.1053/j.gastro.2020.02.068
  199. Arnold, M., Ferlay, J., van Berge Henegouwen, M. I., & Soerjomataram, I. (2020). Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut. 69(9): 1564-1571. PMID: 32606208 doi: 10.1136/gutjnl-2020-321600
  200. Arnold, M., Park, J. Y., Camargo, M. C., Lunet, N., Forman, D., & Soerjomataram, I. (2020). Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut. 69(5): 823-829. PMID: 32001553 doi: 10.1136/gutjnl-2019-320234
  201. Atun, R., Bhakta, N., Denburg, A., Frazier, A. L., Friedrich, P., Gupta, S., . . . Rodriguez-Galindo, C. (2020). Sustainable care for children with cancer: a Lancet Oncology Commission. Lancet Oncol. 21(4): e185-e224. PMID: 32240612 doi: 10.1016/s1470-2045(20)30022-x
  202. Bansal, S., Deshpande, V., Zhao, X., Lauer, J. A., Meheus, F., Ilbawi, A., & Gopalappa, C. (2020). Analysis of Mammography Screening Schedules under Varying Resource Constraints for Planning Breast Cancer Control Programs in Low- and Middle-Income Countries: A Mathematical Study. Med Decis Making. 40(3): 364-378. PMID: 32160823 doi: 10.1177/0272989X20910724
  203. Barr, R. D., Ries, L. A. G., Trama, A., Gatta, G., Steliarova-Foucher, E., Stiller, C. A., & Bleyer, W. A. (2020). A system for classifying cancers diagnosed in adolescents and young adults. Cancer. 126(21): 4634-4659. PMID: 32901932 doi: 10.1002/cncr.33041
  204. Bray, F., Laversanne, M., Weiderpass, E., & Arbyn, M. (2020). Geographic and temporal variations in the incidence of vulvar and vaginal cancers. Int J Cancer. 147(10): 2764-2771. PMID: 32410226 doi: 10.1002/ijc.33055
  205. Brisson, M., Kim, J. J., Canfell, K., Drolet, M., Gingras, G., Burger, E. A., . . . Hutubessy, R. (2020). Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 395(10224): 575-590. PMID: 32007141 doi: 10.1016/s0140-6736(20)30068-4
  206. Cabasag, C. J., Arnold, M., Butler, J., Inoue, M., Trabert, B., Webb, P. M., . . . Soerjomataram, I. (2020). The influence of birth cohort and calendar period on global trends in ovarian cancer incidence. Int J Cancer. 146(3): 749-758. PMID: 30968402 doi: 10.1002/ijc.32322
  207. Cabasag, C. J., Butler, J., Arnold, M., Rutherford, M., Bardot, A., Ferlay, J., . . . Soerjomataram, I. (2020). Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study. Gynecol Oncol. 157(1): 234-244. PMID: 32005583 doi: 10.1016/j.ygyno.2019.12.047
  208. Canfell, K., Kim, J. J., Brisson, M., Keane, A., Simms, K. T., Caruana, M., . . . Hutubessy, R. (2020). Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 395(10224): 591-603. PMID: 32007142 doi: 10.1016/s0140-6736(20)30157-4
  209. Culp, M. B., Soerjomataram, I., Efstathiou, J. A., Bray, F., & Jemal, A. (2020). Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates. Eur Urol. 77(1): 38-52. PMID: 31493960 doi: 10.1016/j.eururo.2019.08.005
  210. de Martel, C., Georges, D., Bray, F., Ferlay, J., & Clifford, G. M. (2020). Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 8(2): e180-e190. PMID: 31862245 doi: 10.1016/s2214-109x(19)30488-7
  211. Di Credico, G., Polesel, J., Dal Maso, L., Pauli, F., Torelli, N., Luce, D., . . . Edefonti, V. (2020). Alcohol drinking and head and neck cancer risk: the joint effect of intensity and duration. Br J Cancer. 123(9): 1456-1463. PMID: 32830199 doi: 10.1038/s41416-020-01031-z
  212. Diaz, A., Soerjomataram, I., Moore, S., Whop, L. J., Bray, F., Hoberg, H., & Garvey, G. (2020). Collection and Reporting of Indigenous Status Information in Cancer Registries Around the World. JCO Glob Oncol. 6: 133-142. PMID: 32031453 doi: 10.1200/JGO.19.00119
  213. Fidler-Benaoudia, M. M., Torre, L. A., Bray, F., Ferlay, J., & Jemal, A. (2020). Lung cancer incidence in young women vs. young men: A systematic analysis in 40 countries. Int J Cancer. 147(3): 811-819. PMID: 32020598 doi: 10.1002/ijc.32809
  214. Florio, A. A., Ferlay, J., Znaor, A., Ruggieri, D., Alvarez, C. S., Laversanne, M., . . . Petrick, J. L. (2020). Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer. 126(11): 2666-2678. PMID: 32129902 doi: 10.1002/cncr.32803
  215. Gadgil, A., Sauvaget, C., Roy, N., Muwonge, R., Lucas, E., & Sankaranarayanan, R. (2020). Setting up a Breast Cancer Awareness Project in Mumbai: Methodology, Experiences and Challenges. J Cancer Educ. 35(3): 579-588. PMID: 30863980 doi: 10.1007/s13187-019-01500-x
  216. Gupta, S., Aitken, J., Bartels, U., Bhakta, N., Bucurenci, M., Brierley, J. D., . . . Frazier, A. L. (2020). Development of paediatric non-stage prognosticator guidelines for population-based cancer registries and updates to the 2014 Toronto Paediatric Cancer Stage Guidelines. Lancet Oncol. 21(9): e444-e451. PMID: 32888473 doi: 10.1016/S1470-2045(20)30320-X
  217. Gupta, S., Harper, A., Ruan, Y., Barr, R., Frazier, A. L., Ferlay, J., . . . Fidler-Benaoudia, M. M. (2020). International Trends in the Incidence of Cancer Among Adolescents and Young Adults. J Natl Cancer Inst. 112(11): 1105-1117. PMID: 32016323 doi: 10.1093/jnci/djaa007
  218. Hall, A. L., Kromhout, H., Schuz, J., Peters, S., Portengen, L., Vermeulen, R., . . . Olsson, A. (2020). Laryngeal Cancer Risks in Workers Exposed to Lung Carcinogens: Exposure-Effect Analyses Using a Quantitative Job Exposure Matrix. Epidemiology. 31(1): 145-154. PMID: 31577634 doi: 10.1097/ede.0000000000001120
  219. Hanly, P., Ortega Ortega, M., Pearce, A., Soerjomataram, I., & Sharp, L. (2020). Advances in the methodological approach to friction period estimation: A European perspective. Soc Sci Med. 264: 113289. PMID: 32836019 doi: 10.1016/j.socscimed.2020.113289
  220. Hassler, M. R., Bray, F., Catto, J. W. F., Grollman, A. P., Hartmann, A., Margulis, V., . . . Faltas, B. M. (2020). Molecular Characterization of Upper Tract Urothelial Carcinoma in the Era of Next-generation Sequencing: A Systematic Review of the Current Literature. Eur Urol. 78(2): 209-220. PMID: 32571725 doi: 10.1016/j.eururo.2020.05.039
  221. Ilbawi, A., Dhaene, G., Meheus, F., & Bertram, M. (2020). Opportunities to improve cancer control and progress towards universal health coverage in Commonwealth nations. Lancet Oncol. 21(7): 876-879. PMID: 32615104 doi: 10.1016/S1470-2045(20)30245-X
  222. Jafari-Delouei, N., Naeimi-Tabiei, M., Fazel, A., Ashaari, M., Hatami, E., Sedaghat, S. M., . . . Roshandel, G. (2020). Descriptive Epidemiology of Lymphoma in Northern Iran: Results from the Golestan Registry 2004-2013. Arch Iran Med. 23(3): 150-154. PMID: 32126782
  223. Ji, X. W., Jiang, Y., Wu, H., Zhou, P., Tan, Y. T., Li, H. L., . . . Xiang, Y. B. (2020). Long-term liver cancer incidence and mortality trends in the Changning District of Shanghai, China. J Dig Dis. 21(4): 230-236. PMID: 32124559 doi: 10.1111/1751-2980.12855
  224. Joko-Fru, W. Y., Jedy-Agba, E., Korir, A., Ogunbiyi, O., Dzamalala, C. P., Chokunonga, E., . . . Parkin, D. M. (2020). The evolving epidemic of breast cancer in sub-Saharan Africa: Results from the African Cancer Registry Network. Int J Cancer. 147(8): 2131-2141. PMID: 32306390 doi: 10.1002/ijc.33014
  225. Joko-Fru, W. Y., Miranda-Filho, A., Soerjomataram, I., Egue, M., Akele-Akpo, M. T., N’da, G., . . . Parkin, D. M. (2020). Breast cancer survival in sub-Saharan Africa by age, stage at diagnosis and human development index: A population-based registry study. Int J Cancer. 146(5): 1208-1218. PMID: 31087650 doi: 10.1002/ijc.32406
  226. Kreimer, A. R., Chaturvedi, A. K., Alemany, L., Anantharaman, D., Bray, F., Carrington, M., . . . Brennan, P. (2020). Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI. Oral Oncol. 108: 104736. PMID: 32502860 doi: 10.1016/j.oraloncology.2020.104736
  227. Kulhanova, I., Forman, D., Vignat, J., Espina, C., Brenner, H., Storm, H. H., . . . Soerjomataram, I. (2020). Tobacco-related cancers in Europe: The scale of the epidemic in 2018. Eur J Cancer. 139: 27-36. PMID: 32957011 doi: 10.1016/j.ejca.2020.07.024
  228. Kulhanova, I., Znaor, A., Shield, K. D., Arnold, M., Vignat, J., Charafeddine, M., . . . Soerjomataram, I. (2020). Proportion of cancers attributable to major lifestyle and environmental risk factors in the Eastern Mediterranean region. Int J Cancer. 146(3): 646-656. PMID: 30882889 doi: 10.1002/ijc.32284
  229. Lambert, P. C., Andersson, T. M., Rutherford, M. J., Myklebust, T. A., & Moller, B. (2020). Reference-adjusted and standardized all-cause and crude probabilities as an alternative to net survival in population-based cancer studies. Int J Epidemiol. 49(5): 1614-1623. PMID: 32829393 doi: 10.1093/ije/dyaa112
  230. Li, M., Brito, J. P., & Vaccarella, S. (2020). Long-Term Declines of Thyroid Cancer Mortality: An International Age-Period-Cohort Analysis. Thyroid. 30(6): 838-846. PMID: 31964280 doi: 10.1089/thy.2019.0684
  231. Li, M., Dal Maso, L., & Vaccarella, S. (2020). Global trends in thyroid cancer incidence and the impact of overdiagnosis. Lancet Diabetes Endocrinol. 8(6): 468-470. PMID: 32445733 doi: 10.1016/S2213-8587(20)30115-7
  232. Lorenzoni, C. F., Ferro, J., Carrilho, C., Colombet, M., & Parkin, D. M. (2020). Cancer in Mozambique: Results from two population-based cancer registries. Int J Cancer. 147(6): 1629-1637. PMID: 32142162 doi: 10.1002/ijc.32953
  233. Lortet-Tieulent, J., Georges, D., Bray, F., & Vaccarella, S. (2020). Profiling global cancer incidence and mortality by socioeconomic development. Int J Cancer. 147(11): 3029-3036. PMID: 32449164 doi: 10.1002/ijc.33114
  234. Mhatre, S., Rajaraman, P., Chatterjee, N., Bray, F., Goel, M., Patkar, S., . . . Dikshit, R. (2020). Mustard oil consumption, cooking method, diet and gallbladder cancer risk in high- and low-risk regions of India. Int J Cancer. 147(6): 1621-1628. PMID: 32142159 doi: 10.1002/ijc.32952
  235. Miranda-Filho, A., & Bray, F. (2020). Global patterns and trends in cancers of the lip, tongue and mouth. Oral Oncol. 102: 104551. PMID: 31986342 doi: 10.1016/j.oraloncology.2019.104551
  236. Miranda-Filho, A., Bray, F., Charvat, H., Rajaraman, S., & Soerjomataram, I. (2020). The world cancer patient population (WCPP): An updated standard for international comparisons of population-based survival. Cancer Epidemiol. 69: 101802. PMID: 32942139 doi: 10.1016/j.canep.2020.101802
  237. Miranda-Filho, A., Pineros, M., Ferreccio, C., Adsay, V., Soerjomataram, I., Bray, F., & Koshiol, J. (2020). Gallbladder and extrahepatic bile duct cancers in the Americas: Incidence and mortality patterns and trends. Int J Cancer. 147(4): 978-989. PMID: 31922259 doi: 10.1002/ijc.32863
  238. Myklebust, T. A., Andersson, T., Bardot, A., Vernon, S., Gavin, A., Fitzpatrick, D., . . . Moller, B. (2020). Can different definitions of date of cancer incidence explain observed international variation in cancer survival? An ICBP SURVMARK-2 study. Cancer Epidemiol. 67: 101759. PMID: 32544801 doi: 10.1016/j.canep.2020.101759
  239. Nakata, K., Colombet, M., Stiller, C. A., Pritchard-Jones, K., & Steliarova-Foucher, E. (2020). Incidence of childhood renal tumours: An international population-based study. Int J Cancer. 147(12): 3313-3327. PMID: 32902866 doi: 10.1002/ijc.33147
  240. Noh, H., Charvat, H., Freisling, H., Olafsdottir, G. H., Olafsdottir, E. J., Tryggvadottir, L., . . . Soerjomataram, I. (2020). Cumulative exposure to premenopausal obesity and risk of postmenopausal cancer: A population-based study in Icelandic women. Int J Cancer. 147(3): 793-802. PMID: 31755107 doi: 10.1002/ijc.32805
  241. Norell, C. H., Butler, J., Farrell, R., Altman, A., Bentley, J., Cabasag, C. J., . . . Harrison, S. (2020). Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care. Int J Gynecol Cancer. 30(11): 1748-1756. PMID: 32784203 doi: 10.1136/ijgc-2020-001403
  242. Panato, C., Vaccarella, S., Dal Maso, L., Basu, P., Franceschi, S., Serraino, D., . . . Mathew, A. (2020). Thyroid Cancer Incidence in India Between 2006 and 2014 and Impact of Overdiagnosis. J Clin Endocrinol Metab. 105(8): 2507-2514. PMID: 32297630 doi: 10.1210/clinem/dgaa192
  243. Parkin, D. M., Hammerl, L., Ferlay, J., & Kantelhardt, E. J. (2020). Cancer in Africa 2018: The role of infections. Int J Cancer. 146(8): 2089-2103. PMID: 31254479 doi: 10.1002/ijc.32538
  244. Petrick, J. L., Florio, A. A., Znaor, A., Ruggieri, D., Laversanne, M., Alvarez, C. S., . . . McGlynn, K. A. (2020). International trends in hepatocellular carcinoma incidence, 1978-2012. Int J Cancer. 147(2): 317-330. PMID: 31597196 doi: 10.1002/ijc.32723
  245. Pilleron, S., Cabasag, C. J., Ferlay, J., Bray, F., Luciani, S., Almonte, M., & Pineros, M. (2020). Cervical cancer burden in Latin America and the Caribbean: Where are we? Int J Cancer. 147(6): 1638-1648. PMID: 32150288 doi: 10.1002/ijc.32956
  246. Ponti, A., Basu, P., Ritchie, D., Anttila, A., Carvalho, A. L., Senore, C., . . . Segnan, N. (2020). Key issues that need to be considered while revising the current annex of the European Council Recommendation (2003) on cancer screening. Int J Cancer. 147(1): 9-13. PMID: 31970768 doi: 10.1002/ijc.32885
  247. Roshandel, G., Ferlay, J., Semnani, S., Fazel, A., Naeimi-Tabiei, M., Ashaari, M., . . . Bray, F. (2020). Recent cancer incidence trends and short-term predictions in Golestan, Iran 2004-2025. Cancer Epidemiol. 67: 101728. PMID: 32554298 doi: 10.1016/j.canep.2020.101728
  248. Ryzhov, A., Bray, F., Ferlay, J., Fedorenko, Z., Goulak, L., Gorokh, Y., . . . Znaor, A. (2020). Recent cancer incidence trends in Ukraine and short-term predictions to 2022. Cancer Epidemiol. 65: 101663. PMID: 31882366 doi: 10.1016/j.canep.2019.101663
  249. Salamat, F., Khandashpour, M., Naeimi-Tabiei, M., Ariannia, A., Ashaari, M., Sedaghat, S., . . . Weiderpass, E. (2020). Increasing trends of lung cancer in Golestan province, Northern Iran (2004-2016). Cancer Epidemiol. 65: 101687. PMID: 32087554 doi: 10.1016/j.canep.2020.101687
  250. Sangrajrang, S., Laversanne, M., Bausom, R., Mery, L., & Bray, F. (2020). Cancer incidence and cancer control in Bangkok, Thailand: Results from the cancer registry 2011-15 and projections to 2035. Cancer Epidemiol. 67: 101765. PMID: 32585431 doi: 10.1016/j.canep.2020.101765
  251. Sengayi-Muchengeti, M., Joko-Fru, W. Y., Miranda-Filho, A., Egue, M., Akele-Akpo, M. T., N’da, G., . . . Parkin, D. M. (2020). Cervical cancer survival in sub-Saharan Africa by age, stage at diagnosis and Human Development Index: A population-based registry study. Int J Cancer. 147(11): 3037-3048. PMID: 32449157 doi: 10.1002/ijc.33120
  252. Snijders, R., Fukinsia, A., Claeys, Y., Mpanya, A., Hasker, E., Meheus, F., . . . Boelaert, M. (2020). Cost of a new method of active screening for human African trypanosomiasis in the Democratic Republic of the Congo. PLoS Negl Trop Dis. 14(12): e0008832. PMID: 33315896 doi: 10.1371/journal.pntd.0008832
  253. Vaccarella, S., & Bray, F. (2020). Are U.S. trends a barometer of future cancer transitions in emerging economies? Int J Cancer. 146(6): 1499-1502. PMID: 31162837 doi: 10.1002/ijc.32485
  254. Wei, W., Zeng, H., Zheng, R., Zhang, S., An, L., Chen, R., . . . He, J. (2020). Cancer registration in China and its role in cancer prevention and control. Lancet Oncol. 21(7): e342-e349. PMID: 32615118 doi: 10.1016/S1470-2045(20)30073-5
  255. Yang, J., Zhou, M., Li, M., Yin, P., Hu, J., Zhang, C., . . . Wang, B. (2020). Fine particulate matter constituents and cause-specific mortality in China: A nationwide modelling study. Environ Int. 143: 105927. PMID: 32619910 doi: 10.1016/j.envint.2020.105927
  256. Znaor, A., Skakkebaek, N. E., Rajpert-De Meyts, E., Laversanne, M., Kulis, T., Gurney, J., . . . Bray, F. (2020). Testicular cancer incidence predictions in Europe 2010-2035: A rising burden despite population ageing. Int J Cancer. 147(3): 820-828. PMID: 31773729 doi: 10.1002/ijc.32810

 

 
View Key Publications

 

 

Cancer Surveillance
About Research Publications Related websites Personnel
Close Reading Mode
UP